financetom
Business
financetom
/
Business
/
PhonePe hits 250 mn user mark, registers 925 mn transactions in October
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PhonePe hits 250 mn user mark, registers 925 mn transactions in October
Nov 2, 2020 4:28 AM

Flipkart-owned fintech platform PhonePe on Monday said it has crossed the 250 million registered user milestone. The company reported over 100 million monthly active users (MAU) and 2.3 billion app sessions in October, a statement said. ”PhonePe had a record month in October, processing 925 million transactions – its highest so far – with an annual TPV (total payment volume) run rate of USD 277 billion. PhonePe also processed 835 million UPI transactions in October, for a market-leading share of over 40 percent,” it added.

Sameer Nigam, CEO and founder of PhonePe, said the company has set a target of crossing 500 million registered users by December 2022. ”In line with our brand ethos of ’Karte Ja. Badhte Ja’, we continue to launch new and innovative products for every strata of Indian society, as well as enable digital payment acceptance across every merchant in every village and town in India,” he added.

PhonePe – which competes with the likes of Paytm, MobiKwik and Google Pay – allows users to send and receive money, recharge mobile and make utility payments as well as buy gold and make investments. It had also launched its ’Switch’ platform that allows customers can place orders on over 220 apps including Ola, Myntra, IRCTC, Goibibo, RedBus and Oyo.

Also Read

: Paytm Postpaid aims to double postpaid service users to 1.5 cr by March 2021

PhonePe is accepted at 13 million merchant outlets across 500 cities nationally.

First Published:Nov 2, 2020 1:28 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
PRESS DIGEST-New York Times business news - June 9
PRESS DIGEST-New York Times business news - June 9
Jun 9, 2026
June 9 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. - ChatGPT-maker OpenAI confidentially filed for a U.S. initial public offering, joining rival Anthropic in a push toward the stock market as investors seek exposure to the artificial intelligence boom....
Live markets: Bitcoin above $63,000 as some traders peg SpaceX's IPO as 'next catalyst'
Live markets: Bitcoin above $63,000 as some traders peg SpaceX's IPO as 'next catalyst'
Jun 9, 2026
07:08 UTC — Tether's dominance surged by most since March 2025 as bitcoin crashedTether (USDT), the leading dollar-pegged stablecoin, saw its market dominance jump 13.55% last week to reach 9%, marking the largest weekly gain since March 2025, according to TradingView data. The sharp upswing coincided with heavy selling pressure on bitcoin, which tumbled nearly 14-16% over the week and...
IDEAYA Biosciences Prices $300 Million Stock Offering
IDEAYA Biosciences Prices $300 Million Stock Offering
Jun 9, 2026
03:41 AM EDT, 06/09/2026 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) said late Monday it priced an underwritten public offering expected to raise about $300 million in gross proceeds. The company said it is selling 5.5 million shares at $27 per share and 5.6 million pre-funded warrants at $26.9999 each. IDEAYA said it also granted underwriters a 30-day option...
GSK boosts lung cancer portfolio with $10.6 billion Nuvalent takeover
GSK boosts lung cancer portfolio with $10.6 billion Nuvalent takeover
Jun 8, 2026
* Deal values Nuvalent ( NUVL ) at $124 per share, a 40% premium to last close * CEO Luke Miels says acquisition expands lung cancer treatments * GSK expects deal to contribute to sales and operating profit from 2027 (Adds detail on deal and context from paragraph 3) June 9 (Reuters) - British drugmaker GSK on Tuesday agreed to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved